Nuvision Biotherapies
1 known investors
NuVision manufactures Omnigen, a wound dressing and grafting material made from amniotic membrane using its patented Tereo process, for use in ocular healing and eye injury care. The company develops amniotic membrane therapies for ophthalmology and provides ROMEO Ophthalmology, an online platform for eye care specialists to record and audit clinical data on amniotic membrane procedures.
BiotechHealthtechMedical Devices
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- NUVISION BIOTHERAPIES LIMITED
- Company number
- 09526225
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 7 Apr 2015
- Registered office
- Medicity, D6 Building, Thane Road, Nottingham, NG90 6BH
- Nature of business (SIC)
- 21200 — Manufacture of pharmaceutical preparations
- Previous names
- NU VISION BIOTHERAPIES LIMITED (2015–2015)
- Accounts
- last made up to 30 Jun 2025 · next due 31 Mar 2027
- Confirmation statement
- last made up to 11 Feb 2026 · next due 25 Feb 2027
Current officers · 6
- Timothy John Gray — director, appointed 19 Jun 2025
- Andrew Hopkinson — director, appointed 20 May 2015
- Timothy James Precious — director, appointed 26 May 2026
- Roger Peter Teasdale — director, appointed 1 Mar 2018
- Noel Waters — director, appointed 19 Jun 2025
- Mercia Fund Management (nominees) Limited — corporate director, appointed 26 Nov 2020
Source: Companies House public register · retrieved 23 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Nuvision Biotherapies do?
- NuVision manufactures Omnigen, a wound dressing and grafting material made from amniotic membrane using its patented Tereo process, for use in ocular healing and eye injury care. The company develops amniotic membrane therapies for ophthalmology and provides ROMEO Ophthalmology, an online platform for eye care specialists to record and audit clinical data on amniotic membrane procedures.
- Who are Nuvision Biotherapies's investors?
- Nuvision Biotherapies's investors include Maven Capital Partners.